[HTML][HTML] Trends and perspectives for improving quality of chronic kidney disease care: conclusions from a Kidney Disease: Improving Global Outcomes (KDIGO) …

KU Eckardt, C Delgado, HJL Heerspink… - Kidney international, 2023 - Elsevier
Chronic kidney disease (CKD) affects over 850 million people globally, and there is an
urgent need to prevent its development and progression. During the last decade, new …

Current understanding of the molecular mechanisms of circulating permeability factor in focal segmental glomerulosclerosis

G Salfi, F Casiraghi, G Remuzzi - Frontiers in immunology, 2023 - frontiersin.org
The pathogenetic mechanisms underlying the onset and the post-transplant recurrence of
primary focal segmental glomerulosclerosis (FSGS) are complex and remain yet to be fully …

Sustained alterations in proximal tubule gene expression in primary culture associate with HNF4A loss

AC Telang, JT Ference-Salo, MC McElliott… - Scientific Reports, 2024 - nature.com
Primary cultures of proximal tubule cells are widely used to model the behavior of kidney
epithelial cells in vitro. However, de-differentiation of primary cells upon culture has been …

[HTML][HTML] Rationale and design of the Nephrotic Syndrome Study Network (NEPTUNE) Match in glomerular diseases: designing the right trial for the right patient, today

H Trachtman, H Desmond, AL Williams, LH Mariani… - Kidney international, 2024 - Elsevier
Glomerular diseases are classified using a descriptive taxonomy that is not reflective of the
heterogeneous underlying molecular drivers. This limits not only diagnostic and therapeutic …

An integrated organoid omics map extends modeling potential of kidney disease

M Lassé, J El Saghir, CC Berthier, S Eddy… - Nature …, 2023 - nature.com
Kidney organoids are a promising model to study kidney disease, but their use is
constrained by limited knowledge of their functional protein expression profile. Here, we …

[HTML][HTML] Scaffold protein SH3BP2 signalosome is pivotal for immune activation in nephrotic syndrome

T Srivastava, RE Garola, J Zhou, VC Boinpelly… - JCI insight, 2024 - ncbi.nlm.nih.gov
Despite clinical use of immunosuppressive agents, the immunopathogenesis of minimal
change disease (MCD) and focal segmental glomerulosclerosis (FSGS) remains unclear …

Pathogenesis of Focal Segmental Glomerulosclerosis and Related Disorders

MM Altintas, S Agarwal, Y Sudhini, K Zhu… - Annual Review of …, 2025 - annualreviews.org
Focal segmental glomerulosclerosis (FSGS) is the morphologic manifestation of a spectrum
of kidney diseases that primarily impact podocytes, cells that create the filtration barrier of …

[HTML][HTML] Challenges and Opportunities for the Clinical Translation of Spatial Transcriptomics Technologies

KD Smith, DK Prince, JW MacDonald… - Glomerular …, 2024 - karger.com
Background: The first spatially resolved transcriptomics platforms, GeoMx (Nanostring) and
Visium (10x Genomics) were launched in 2019 and were recognized as the method of the …

Interferon-γ induces combined pyroptotic angiopathy and APOL1 expression in human kidney disease

BA Juliar, IB Stanaway, F Sano, H Fu, KD Smith… - Cell Reports, 2024 - cell.com
Elevated interferon (IFN) signaling is associated with kidney diseases including COVID-19,
HIV, and apolipoprotein-L1 (APOL1) nephropathy, but whether IFNs directly contribute to …

[HTML][HTML] Identification of glomerular and plasma apolipoprotein M as novel biomarkers in glomerular disease

Y Drexler, J Molina, T Elfassy, R Ma… - Kidney International …, 2023 - Elsevier
Introduction Dysregulation of sphingolipid and cholesterol metabolism contributes to the
pathogenesis of glomerular diseases (GDs). Apolipoprotein M (ApoM) promotes cholesterol …